Cited by 162Adrenal and Paraganglionic TumorsPituitary Gland Disorders and TreatmentsAdrenal Hormones and Disorders

The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.

Development of overt Cushing’s syndrome in patients with adrenal incidentaloma

Open access

Barzon, L, Fallo, F, Sonino, N, Boscaro, M·2002·European Journal of Endocrinology

Open this paper in CoChat — free account

Abstract

OBJECTIVE: The natural course of adrenal incidentalomas, especially those with subclinical autonomous glucocorticoid production, i.e. subclinical Cushing's syndrome, and the risk that such conditions will evolve towards overt Cushing's syndrome are unknown. DESIGN: Longitudinal follow-up evaluation of a series of 284 consecutive patients with adrenal incidentaloma. METHODS AND RESULTS: Out of 284 consecutive patients with adrenal incidentaloma studied at our Institution in the last 15 years, 98 patients (23 with subclinical hypercortisolism) underwent surgery. Of 130 non-operated patients with a follow-up of at least 1 year, eight had subclinical hypercortisolism at diagnosis. We describe in detail four patients who developed overt Cushing's syndrome after 1-3 years of follow-up. Only one of these patients had subclinical hypercortisolism at first diagnosis. Estimated cumulative risk for a non-secreting adrenal incidentaloma to develop subclinical hyperfunction was 3.8% after 1 year and 6.6% after 5 years. For patients with masses with subclinical autonomous glucocorticoid overproduction, estimated cumulative risk to develop overt Cushing's syndrome was 12.5% after 1 year. CONCLUSIONS: In patients with adrenal incidentalomas the risk of progression towards overt Cushing's syndrome is not low, at variance with previous reports. A careful biochemical and hormonal follow-up is advisable in all patients who do not need surgery at first presentation.

Integrity signals

Registry

Crossref · 10.1530/eje.0.1460061

Cites

16 of 16 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

The text we found for this paper looks like another document, so its claims and self-check weren’t run. The registry and citation checks still apply.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The text we found for this paper looks like another document, so the self-check wasn’t run.

Subclinical Cushing's Syndrome in Patients with Adrenal Incidentaloma: Clinical and Biochemical Features
Rossi, R., Tauchmanovà, L., Luciano, A., Martino, M. D., Battista, C., Viscovo, L. D., Nuzzo, V., & Lombardi, G. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.4.6515 · Cited by 415
Preclinical Cushing's syndrome in adrenal "incidentalomas": comparison with adrenal Cushing's syndrome
Reincke, M., Nieke, J., Krestin, G. P., Saeger, W., Allolio, B., & Winkelmann, W. (1992) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.75.3.1517373 · Cited by 346
Cushing's syndrome
Boscaro, M., Barzon, L., Fallo, F., & Sonino, N. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04172-6 · Cited by 344
Self-citation
Subclinical Cushing’s syndrome
Reincke, M. (2000) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(05)70115-8 · Cited by 285
Risk Factors and Long-Term Follow-Up of Adrenal Incidentalomas1
Barzon, L., Scaroni, C. M., Sonino, N., Fallo, F., Paoletta, A., & Boscaro, M. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.2.5444 · Cited by 255
Self-citation
Subclinical Cushing's syndrome in adrenal incidentaloma.
Terzolo, Osella, Alì, Borretta, Cesario, Paccotti, & Angeli, A. (1998) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1998.00357.x · Cited by 198
Incidentally Discovered Adrenal Tumors: Endocrine and Scintigraphic Correlates1
Barzon, L., Scaroni, C. M., Sonino, N., Fallo, F., Gregianin, M., Macrì, C., & Boscaro, M. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.1.4501 · Cited by 184
Self-citation
Abnormalities of endocrine function in patients with clinically silent adrenal masses.
Ambrosi, B., Peverelli, S., Passini, E., Re, T., Ferrario, R., Colombo, P., Sartorio, A., & Faglia, G. (1995) · European Journal of Endocrinology · doi:10.1530/eje.0.1320422 · Cited by 136
DIAGNOSIS AND MANAGEMENT OF ADRENAL INCIDENTALOMAS
Barzon, L., & Boscaro, M. (2000) · The Journal of Urology · doi:10.1016/s0022-5347(05)67888-3 · Cited by 111
Self-citation
Epidemiology of Cushing’s Syndrome and Subclinical Disease
Ross, N. S. (1994) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(18)30082-3 · Cited by 104

Show all 16 references

Sorted by citations

The Incidentally Discovered Adrenal Mass
Young, W. F. (2007) · New England Journal of Medicine · doi:10.1056/nejmcp065470 · Cited by 1,090
The clinically inapparent adrenal mass: update in diagnosis and management
Mansmann, G., Lau, J., Balk, E., Rothberg, M., Miyachi, Y., & Bornstein, S. R. (2004) · Endocrine Reviews · doi:10.1210/er.2002-0031 · Cited by 781
Prevalence of adrenal incidentaloma in a contemporary computerized tomography series
Bovio, S., Cataldi, A., Reimondo, G., Sperone, P., Novello, S., Berruti, A., Borasio, P., Fava, C., Dogliotti, L., Scagliotti, G. V., et al. (2006) · Journal of Endocrinological Investigation · doi:10.1007/bf03344099 · Cited by 712
Prevalence and natural history of adrenal incidentalomas
Barzon, L., Sonino, N., Fallo, F., Palu, G., & Boscaro, M. (2003) · European Journal of Endocrinology · doi:10.1530/eje.0.1490273 · Cited by 642
Self-citation
The Pathogenetic Role of Cortisol in the Metabolic Syndrome: A Hypothesis
Anagnostis, P. G., Athyros, V. G., Τζιόμαλος, Κ., Karagiannis, A. I., & Mikhailidis, D. P. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0370 · Cited by 625
AME Position Statement on adrenal incidentaloma
Terzolo, M., Stigliano, A., Chiodini, I., Loli, P., Furlani, L., Arnaldi, G., Reimondo, G., Pia, A., Toscano, V., Zini, M., et al. (2011) · European Journal of Endocrinology · doi:10.1530/eje-10-1147 · Cited by 523
Cardiovascular events and mortality in patients with adrenal incidentalomas that are either non-secreting or associated with intermediate phenotype or subclinical Cushing’s syndrome: a 15-year retrospective study
Di Dalmazi, G., Vicennati, V., Garelli, S., Casadio, E., Rinaldi, E., Giampalma, E., Mosconi, C., Golfieri, R., Paccapelo, A., Pagotto, U., et al. (2014) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(13)70211-0 · Cited by 415
Measuring cortisol in serum, urine and saliva—Are our assays good enough?
El-Farhan, N., Rees, D. A., & Evans, C. (2017) · Annals of Clinical Biochemistry: International Journal of Laboratory Medicine · doi:10.1177/0004563216687335 · Cited by 395
Adrenal incidentaloma
Sherlock, M., Scarsbrook, A., Abbas, A., Fraser, S., Limumpornpetch, P., Dineen, R., & Stewart, P. M. (2020) · Endocrine Reviews · doi:10.1210/endrev/bnaa008 · Cited by 347
“A large number of clinical studies have investigated the characteristics of AIs (Table 3 (39, 40,42,46-84)).”
Background
Occult Cushing’s syndrome in type-2 diabetes
Catargi, B., Rigalleau, V., Poussin, A., Ronci-Chaix, N., Bex, V., Vergnot, V., Gin, H., Roger, P., & Tabarin, A. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030254 · Cited by 287
Diagnosis and Treatment of Subclinical Hypercortisolism
Chiodini, I. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-2722 · Cited by 279
Clinical Utility of Noncontrast Computed Tomography Attenuation Value (Hounsfield Units) to Differentiate Adrenal Adenomas/Hyperplasias from Nonadenomas: Cleveland Clinic Experience
Hamrahian, A. H., Ioachimescu, A. G., Remer, E. M., Motta-Ramírez, G. A., Bogabathina, H., Levin, H. S., Reddy, S. S. K., Gill, I. S., SIPERSTEIN, A. E., & Bravo, E. L. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1627 · Cited by 264
Natural History of Adrenal Incidentalomas With and Without Mild Autonomous Cortisol Excess: A Systematic Review and Meta-analysis
Elhassan, Y. S., Alahdab, F., Prete, A., Delivanis, D. A., Khanna, A., Prokop, L., Murad, M. H., O'Reilly, M. W., Arlt, W., & Bancos, I. (2019) · Annals of Internal Medicine · doi:10.7326/m18-3630 · Cited by 263
Long-term follow-up in adrenal incidentalomas: an Italian multicenter study
Morelli, V., Reimondo, G., Giordano, R., Della Casa, S., Policola, C., Palmieri, S., Salcuni, A. S., Dolci, A., Mendola, M., Arosio, M., et al. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-3527 · Cited by 223
Progressively increased patterns of subclinical cortisol hypersecretion in adrenal incidentalomas differently predict major metabolic and cardiovascular outcomes: a large cross-sectional study
Dalmazi, G. D., Vicennati, V., Rinaldi, E., Morselli‐Labate, A. M., Giampalma, E., Mosconi, C., Pagotto, U., & Pasquali, R. (2012) · European Journal of Endocrinology · doi:10.1530/eje-11-1039 · Cited by 186
Subclinical Cushing’s syndrome in adrenal incidentalomas
Terzolo, M., Bovio, S., Reimondo, G., Pia, A., Osella, G., Borretta, G., & Angeli, A. (2005) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2005.01.008 · Cited by 179
Controversies in hypertension
Kaplan, N. M., & Opie, L. H. (2006) · The Lancet · doi:10.1016/s0140-6736(06)67965-8 · Cited by 164
Clinical guidelines for the management of adrenal incidentaloma
Lee, J.-M., Kim, M. K., Ko, S.-H., Koh, J.-M., Kim, B.-Y., Kim, S. W., Kim, S.-K., Kim, H. J., Ryu, O.-H., Park, J., et al. (2017) · Endocrinology and Metabolism · doi:10.3803/enm.2017.32.2.200 · Cited by 147
Guidelines for the management of the incidentally discovered adrenal mass
Kapoor, A., Morris, T., & Rebello, R. (2011) · Canadian Urological Association Journal · doi:10.5489/cuaj.11135 · Cited by 137
Medical and Surgical Evaluation and Treatment of Adrenal Incidentalomas
Zeiger, M. A., Siegelman, S. S., & Hamrahian, A. H. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-0085 · Cited by 135
Exploration and management of adrenal incidentalomas.
Tabarin, A., Bardet, S., Bertherat, J. Y., Dupas, B., Chabre, O., Hamoir, E., Laurent, F., Tenenbaum, F., Cazalda, M., Lefèbvre, H., et al. (2008) · Annales d Endocrinologie · doi:10.1016/j.ando.2008.09.003 · Cited by 129
Adrenal incidentaloma—follow-up results from a Swedish prospective study.
Bülow, B., Jansson, S., Juhlin, C., Steen, L., Thorén, M., Wahrenberg, H., Valdemarsson, S., Wängberg, B., Ahréen, B., & _, _. (2006) · European Journal of Endocrinology · doi:10.1530/eje.1.02110 · Cited by 124
Endogenous subclinical hypercortisolism: diagnostic uncertainties and clinical implications.
Tsagarakis, S., Vassiliadi, D., & Thalassinos, N. (2006) · Journal of Endocrinological Investigation · doi:10.1007/bf03344133 · Cited by 113
Hormonal activity of adrenal incidentalomas: results from a long-term follow-up study
Vassilatou, E., Vryonidou, A., Michalopoulou, S., Manolis, J., Caratzas, J., Phenekos, C., & Tzavara, I. (2009) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03492.x · Cited by 112
Increased mortality in patients with adrenal incidentalomas and autonomous cortisol secretion: a 13-year retrospective study from one center
Patrova, J., Kjellman, M., Wahrenberg, H., & Falhammar, H. (2017) · Endocrine · doi:10.1007/s12020-017-1400-8 · Cited by 109
Subclinical hypercortisolism: correlation between biochemical diagnostic criteria and clinical aspects
Morelli, V., Masserini, B., Salcuni, A. S., Eller‐Vainicher, C., Savoca, C., Viti, R., Coletti, F., Guglielmi, G., Battista, C., Iorio, L., et al. (2010) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2010.03794.x · Cited by 107
The limited role of midnight salivary cortisol levels in the diagnosis of subclinical hypercortisolism in patients with adrenal incidentaloma
Masserini, B., Morelli, V., Bergamaschi, S., Ermetici, F., Eller-Vainicher, C., Barbieri, A. M., Maffini, M. A., Scillitani, A., Ambrosi, B., Beck-Peccoz, P., et al. (2009) · European Journal of Endocrinology · doi:10.1530/eje-08-0485 · Cited by 106
Prevalence of subclinical Cushing’s syndrome in 70 patients with adrenal incidentaloma: clinical, biochemical and surgical outcomes
EMRAL, R., UYSAL, A. R., ASIK, M., GULLU, S., CORAPCIOGLU, D., TONYUKUK, V., & ERDOGAN, G. (2003) · Endocrine Journal · doi:10.1507/endocrj.50.399 · Cited by 104
Evaluation of the Cardiovascular Risk in Patients with Subclinical Cushing Syndrome Before and After Surgery
Erbil, Y., Ademoğlu, E., Özbey, N., Barbaros, U., Yanık, B. T., Salmaslıoğlu, A., Bozbora, A., & Özarmağan, S. (2006) · World Journal of Surgery · doi:10.1007/s00268-005-0681-x · Cited by 102
Adrenalectomy may improve cardiovascular and metabolic impairment and ameliorate quality of life in patients with adrenal incidentalomas and subclinical Cushing’s syndrome
Iacobone, M., Citton, M., Viel, G., Boetto, R., Bonadio, I., Mondi, I., Tropea, S., Nitti, D., & Favia, G. (2012) · Surgery · doi:10.1016/j.surg.2012.08.054 · Cited by 101
Long-term morphological, hormonal, and clinical follow-up in a single unit on 118 patients with adrenal incidentalomas
Giordano, R., Marinazzo, E., Berardelli, R., Picu, A., Maccario, M., Ghigo, E., & Arvat, E. (2010) · European Journal of Endocrinology · doi:10.1530/eje-09-0957 · Cited by 99
Cardiovascular risks and their long-term clinical outcome in patients with subclinical Cushing’s syndrome
TSUIKI, M., TANABE, A., TAKAGI, S., NARUSE, M., & TAKANO, K. (2008) · Endocrine Journal · doi:10.1507/endocrj.k07e-177 · Cited by 97
Changes in Adenosine 5′-Monophosphate-Activated Protein Kinase as a Mechanism of Visceral Obesity in Cushing’s Syndrome
Kola, B., Christ‐Crain, M., Lolli, F., Arnaldi, G., Giacchetti, G., Boscaro, M., Grossman, A. B., & Korbonits, M. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1297 · Cited by 89
Self-citation
Adrenal incidentaloma: a diagnostic challenge
Anagnostis, P. G., Karagiannis, A. I., Τζιόμαλος, Κ., Kakafika, A. I., Athyros, V. G., & Mikhailidis, D. P. (2009) · HORMONES · doi:10.14310/horm.2002.1233 · Cited by 79
Autonomous cortisol secretion in adrenal incidentalomas
Castro, M. A., Núñez, M. A. S., & Marazuela, M. (2019) · Endocrine · doi:10.1007/s12020-019-01888-y · Cited by 76
Adrenal incidentalomas
Aron, D. C., Terzolo, M., & Cawood, T. (2012) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2011.06.012 · Cited by 74
Subclinical Cushing's syndrome in adrenal incidentalomas
Sippel, R. S., & Chen, H. (2004) · Surgical Clinics of North America · doi:10.1016/j.suc.2004.01.001 · Cited by 72
Adrenal incidentaloma: evaluation and management
Singh, P. K., & Buch, H. (2008) · Journal of Clinical Pathology · doi:10.1136/jcp.2006.044313 · Cited by 70
Adrenal lesion frequency: a prospective, cross-sectional CT study in a defined region, including systematic re-evaluation
Hammarstedt, L., Muth, A., Wängberg, B., Björneld, L., Sigurjónsdóttir, H. A., Götherström, G., Almqvist, E., Widell, H., Carlsson, S., Ander, S., et al. (2010) · Acta Radiologica · doi:10.3109/02841851.2010.516016 · Cited by 70
Change in Adrenal Mass Size as a Predictor of a Malignant Tumor
Pantalone, K. M., Gopan, T., Remer, E. M., Faiman, C., Ioachimescu, A. G., Levin, H. S., SIPERSTEIN, A. E., Berber, E., Shepardson, L. B., Bravo, E. L., et al. (2010) · Endocrine Practice · doi:10.4158/ep09351.or · Cited by 68
Subclinical Cushing’s syndrome
Leo, M. D., Cozzolino, A., Colao, A. A. L., & Pivonello, R. (2012) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2012.02.001 · Cited by 65
Untitled work
Vassilatou (2014) · doi:10.1530/eje-13-0848 · Cited by 61
The clinical significance of adrenal incidentalomas
Androulakis, I. I., Kaltsas, G., Piaditis, G. P., & Grossman, A. B. (2011) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2010.02436.x · Cited by 61
Usefulness of adrenal scintigraphy in the follow-up of adrenocortical incidentalomas: a prospective multicenter study
Fagour, C., Bardet, S., Rohmer, V., Arimone, Y., Lecomte, P., Valli, N., & Tabarin, A. (2008) · European Journal of Endocrinology · doi:10.1530/eje-08-0299 · Cited by 58
Clinical characteristics and follow-up of Korean patients with adrenal incidentalomas
Cho, Y. Y., Suh, S., Joung, J. Y., Jeong, H., Je, D., Yoo, H., Park, T. K., Min, Y., Kim, K., & Kim, J. H. (2013) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2013.28.5.557 · Cited by 57
Adrenal incidentalomas — a continuing management dilemma
Nawar, R., & Aron, D. C. (2005) · Endocrine Related Cancer · doi:10.1677/erc.1.00951 · Cited by 56
Prevalence of Functioning Adrenal Incidentalomas: A Systematic Review and Meta-analysis
Sconfienza, E., Tetti, M., Forestiero, V., Veglio, F., Mulatero, P., & Monticone, S. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad044 · Cited by 50
Cushing’s syndrome in a clinic population with diabetes
Newsome, S., Chen, K., Hoang, J., Wilson, J. D., Potter, J. M., & Hickman, P. E. (2008) · Internal Medicine Journal · doi:10.1111/j.1445-5994.2007.01434.x · Cited by 48
Adrenal incidentalomas and subclinical Cushing's syndrome: diagnosis and treatment.
Mazzuco, T. L., Bourdeau, I., & Lacroix, A. (2009) · Current Opinion in Endocrinology, Diabetes & Obesity · doi:10.1097/med.0b013e32832b7043 · Cited by 48
Concomitant alterations of metabolic parameters, cardiovascular risk factors and altered cortisol secretion in patients with adrenal incidentalomas during prolonged follow‐up
Papanastasiou, L., Alexandraki, K., Androulakis, I. I., Fountoulakis, S., Kounadi, T., Markou, Α., Tsiavos, V., Samara, C., Papaioannou, T., Piaditis, G. P., et al. (2016) · Clinical Endocrinology · doi:10.1111/cen.13294 · Cited by 49
Six controversial issues on subclinical Cushing’s syndrome
on behalf of the ABC Group, Chiodini, I., Albani, A., Ambrogio, A. G., Campo, M., Martino, M. C. D., Marcelli, G., Morelli, V., Zampetti, B., Colao, A. A. L., et al. (2016) · Endocrine · doi:10.1007/s12020-016-1017-3 · Cited by 47
Cardiovascular outcomes in autonomous cortisol secretion and nonfunctioning adrenal adenoma: a systematic review
Park, J., De Luca, A., Dutton, H., Malcolm, J. C., & Doyle, M.-A. (2019) · Journal of the Endocrine Society · doi:10.1210/js.2019-00090 · Cited by 46
Cardiovascular and metabolic risk factors in patients with subclinical Cushing
Petramala, L., Olmati, F., Concistrè, A., Russo, R., Mezzadri, M., Soldini, M., Vincentis, G. D., Iannucci, G., Toma, G. D., & Letizia, C. (2020) · Endocrine · doi:10.1007/s12020-020-02297-2 · Cited by 50
First-line screening tests for Cushing’s syndrome in patients with adrenal incidentaloma: the role of urinary free cortisol measured by LC-MS/MS
Ceccato, F., Antonelli, G., Frigo, A. C., Regazzo, D., Plebani, M., Boscaro, M., & Scaroni, C. (2017) · Journal of Endocrinological Investigation · doi:10.1007/s40618-017-0644-8 · Cited by 44
Self-citation
Cardiometabolic profile of non-functioning and autonomous cortisol-secreting adrenal incidentalomas. Is the cardiometabolic risk similar or are there differences?
Castro, M. A., Lázaro, C. R., Ramírez, P. A. P., Hernández, M. C., Núñez, M. A. S., & Marazuela, M. (2019) · Endocrine · doi:10.1007/s12020-019-02066-w · Cited by 44
Guía práctica sobre la evaluación inicial, seguimiento y tratamiento de los incidentalomas adrenales. Grupo de patología adrenal de la Sociedad Española de Endocrinología y Nutrición
Castro, M. A., Guevara, M. I., Gutiérrez, M. C., Ramírez, P. A. P., Gimeno, P. G., Hanzu, F. A., & Lamas, C. (2020) · Endocrinología Diabetes y Nutrición · doi:10.1016/j.endinu.2020.03.002 · Cited by 44
cAMP signaling in cortisol-producing adrenal adenoma
Calebiro, D., Dalmazi, G. D., Bathon, K., Ronchi, C. L., & Beuschlein, F. (2015) · European Journal of Endocrinology · doi:10.1530/eje-15-0353 · Cited by 42
Clinical characteristics of adrenocortical tumors in children
Chen, Q., Su, Z., Li, Y., Ma, H., Chen, H.-S., & Du, M. (2011) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem.2011.175 · Cited by 40
Prospective evaluation of tumor size and hormonal status in adrenal incidentalomas
Yener, S., Ertilav, S., Seçil, M., Demir, T., Akıncı, B., Kebapçılar, L., Comlekci, A., Bayraktar, F., & Yeşil, S. (2009) · Journal of Endocrinological Investigation · doi:10.1007/bf03346546 · Cited by 40
The urinary steroid profile in patients diagnosed with adrenal incidentaloma
Kotłowska, A., Maliński, E., Sworczak, K., Kumirska, J., & Stepnowski, P. (2009) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2008.12.027 · Cited by 36
Clinical Characteristics and Follow-Up Results of Adrenal Incidentaloma
Yılmaz, N., Avşar, E., Tazegül, G., Sarı, R., Altunbaş, H., & Balcı, M. K. (2020) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-1079-4915 · Cited by 38
Gonadectomy in mice of the inbred strain CE/J induces proliferation of sub-capsular adrenal cells expressing gonadal marker genes
Johnsen, I. K., Slawik, M., Shapiro, I., Hartmann, M. F., Wudy, S. A., Looyenga, B. D., Hammer, G. D., Reincke, M., & Beuschlein, F. (2006) · Journal of Endocrinology · doi:10.1677/joe.1.06750 · Cited by 36
Urine metabolomics analysis for adrenal incidentaloma activity detection and biomarker discovery
Kotłowska, A., Sworczak, K., & Stepnowski, P. (2011) · Journal of Chromatography B · doi:10.1016/j.jchromb.2010.12.021 · Cited by 37
Subclinical Cushing’s syndrome: Current concepts and trends
Zografos, G. N., Perysinakis, I., & Vassilatou, E. (2014) · HORMONES · doi:10.14310/horm.2002.1506 · Cited by 33
Clinical Benefits of Unilateral Adrenalectomy in Patients with Subclinical Hypercortisolism Due to Adrenal Incidentaloma: Results from a Single Center
Petramala, L., Cavallaro, G., Galassi, M., Marinelli, C., Tonnarini, G., Concistrè, A., Costi, U., Bufi, M., Lucia, P., Vincentis, G. D., et al. (2017) · High Blood Pressure & Cardiovascular Prevention · doi:10.1007/s40292-017-0182-7 · Cited by 34
Incidentally Discovered Adrenal Mass
Song, J. H., & Mayo-Smith, W. W. (2010) · Radiologic Clinics of North America · doi:10.1016/j.rcl.2010.10.006 · Cited by 32
Clinical Characteristics and Metabolic Features of Patients with Adrenal Incidentalomas with or without Subclinical Cushing's Syndrome
Kim, B., Chun, A. R., Kim, K.-J., Jung, C., Kang, S. K., Mok, J., & Kim, C. (2014) · Endocrinology and Metabolism · doi:10.3803/enm.2014.29.4.457 · Cited by 32
Evaluating and managing adrenal incidentalomas.
Gopan, T., Remer, E. M., & Hamrahian, A. H. (2006) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.73.6.561 · Cited by 31
Management of adrenal incidentaloma
Ménégaux, F., Chéreau, N., Peix, J.-L., Christou, N., Lifante, J. C., Paladino, N. C., Sebag, F. A., Ghander, C., Trésallet, C., & Mathonnet, M. (2014) · Journal of Visceral Surgery · doi:10.1016/j.jviscsurg.2014.07.002 · Cited by 32
The Role of Adrenal Scintigraphy in the Diagnosis of Subclinical Cushing’s Syndrome and the Prediction of Post‐surgical Hypoadrenalism
Ricciato, M. P., Donna, V. D., Perotti, G., Pontecorvi, A., Bellantone, R. D. A., & Corsello, S. M. (2014) · World Journal of Surgery · doi:10.1007/s00268-014-2482-6 · Cited by 33
Investigation of BRAFand CTNNB1 activating mutations in adrenocortical tumors
Masi, G., Lavezzo, E., Iacobone, M., Favia, G., Palù, G., & Barzon, L. (2009) · Journal of Endocrinological Investigation · doi:10.1007/bf03346515 · Cited by 29
Self-citation
Adrenal Incidentalomas
Ioachimescu, A. G., Remer, E. M., & Hamrahian, A. H. (2015) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2015.02.005 · Cited by 28
Adrenal Incidentalomas: Diagnostic Evaluation and Long-Term Follow-Up
Vilar, L., Freitas, M., Canadas, V., Albuquerque, J., Botelho, C., Egito, C. S., Arruda, M., Silva, L. M. E., Coelho, C., Casulari, L. A., et al. (2008) · Endocrine Practice · doi:10.4158/ep.14.3.269 · Cited by 28
Observation or laparoscopic adrenalectomy for adrenal incidentaloma? A surgical decision analysis.
Brunaud, L., Kebebew, E., Sebag, F. A., Zarnegar, R., Clark, O. H., & Duh, Q. (2006) · PubMed · Cited by 26
Clinical features, risk of mass enlargement, and development of endocrine hyperfunction in patients with adrenal incidentalomas: a long-term follow-up study
Falcetta, P., Orsolini, F., Benelli, E., Agretti, P., Vitti, P., Cosmo, C. D., & Tonacchera, M. (2020) · Endocrine · doi:10.1007/s12020-020-02476-1 · Cited by 25
Subclinical Cushing’s syndrome in patients with bilateral compared to unilateral adrenal incidentalomas: a systematic review and meta-analysis
Paschou, S. Α., Kandaraki, E., Dimitropoulou, F., Goulis, D. G., & Vryonidou, A. (2015) · Endocrine · doi:10.1007/s12020-015-0776-6 · Cited by 23
Insulin resistance and adrenal incidentalomas: A bidirectional relationship
Sydney, G. I., Ioakim, K. J., & Paschou, S. Α. (2018) · Maturitas · doi:10.1016/j.maturitas.2018.12.002 · Cited by 23
Practical guide on the initial evaluation, follow-up, and treatment of adrenal incidentalomas. Adrenal Diseases Group of the Spanish Society of Endocrinology and Nutrition
Castro, M. A., Guevara, M. I., Gutiérrez, M. C., Ramírez, P. A. P., Gimeno, P. G., Hanzu, F. A., & Lamas, C. (2020) · Endocrinología Diabetes y Nutrición (English ed ) · doi:10.1016/j.endien.2020.08.010 · Cited by 22
Management of the Incidental Adrenal Mass
Thomas, A. Z., Blute, M. L., Seitz, C., Habra, M. A., & Karam, J. A. (2016) · European Urology Focus · doi:10.1016/j.euf.2015.12.006 · Cited by 22
Incidental and Metastatic Adrenal Masses
Mannelli, M., Colagrande, S., Valeri, A., & Parenti, G. (2010) · Seminars in Oncology · doi:10.1053/j.seminoncol.2010.10.018 · Cited by 20
Subclinical Cushing Syndrome
Starker, L. F., Kunstman, J. W., & Carling, T. (2014) · Surgical Clinics of North America · doi:10.1016/j.suc.2014.02.008 · Cited by 21
A comprehensive approach to adrenal incidentalomas
Mantero, F., & Albiger, N. M. E. (2004) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302004000500003 · Cited by 21
Hormonal activity in clinically silent adrenal incidentalomas
Babińska, A., Siekierska-Hellmann, M., Błaut, K., Lewczuk, A., Wiśniewski, P., Gnacińska, M., Obołończyk, Ł., Świątkowska−Stodulska, R., & Sworczak, K. (2012) · Archives of Medical Science · doi:10.5114/aoms.2012.27288 · Cited by 20
Evaluation and management of pituitary incidentalomas—revisiting an acquaintance
Krikorian, A., & Aron, D. C. (2006) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0122 · Cited by 20
New Approaches to the Minimally Invasive Treatment of Adrenal Lesions
Ogilvie, J. B., & Duh, Q. (2005) · The Cancer Journal · doi:10.1097/00130404-200501000-00010 · Cited by 20
PRKACA Mutations in Adrenal Adenomas: Genotype/Phenotype Correlations
Dalmazi, G. D., & Beuschlein, F. (2016) · Hormone and Metabolic Research · doi:10.1055/s-0042-120416 · Cited by 18
Preclinical Models of Adrenocortical Cancer
Sedlack, A. J. H., Hatfield, S. J., Kumar, S., Arakawa, Y., Roper, N., Sun, N.-Y., Nilubol, N., Kiseljak‐Vassiliades, K., Hoang, C. D., Bergsland, E. K., et al. (2023) · Cancers · doi:10.3390/cancers15112873 · Cited by 17
Federal clinical practice guidelines on the diagnostics and treatment of adrenocortical cancer
Mel'nichenko, G. A., Stilidi, I. S., Alekseev, B. Y., Gorbunova, V. A., Beltsevich, D. G., Райхман, А. О., Kuznetsov, N. S., Zhukov, N. V., & Bokhyan, V. Y. (2014) · Problems of Endocrinology · doi:10.14341/probl201460251-67 · Cited by 17
Adrenal Incidentalomas: Presentation and Clinical Work-Up
Beuschlein, F. (2007) · Hormone Research in Paediatrics · doi:10.1159/000110623 · Cited by 16
Diagnosis of silent pheochromocytoma and paraganglioma
Clifton-Bligh, R. J. (2012) · Expert Review of Endocrinology & Metabolism · doi:10.1586/eem.12.76 · Cited by 17
Adipokine and cytokine levels in non-functioning adrenal incidentalomas (NFAI)
Babińska, A., Kaszubowski, M. F., & Sworczak, K. (2018) · Endocrine Journal · doi:10.1507/endocrj.ej18-0066 · Cited by 16
Evaluation of salivary cortisol measurements for the diagnosis of subclinical Cushing’s syndrome
Tateishi, Y., Kouyama, R., Mihara, M., Doi, M., Yoshimoto, T., & Hirata, Y. (2012) · Endocrine Journal · doi:10.1507/endocrj.ej11-0204 · Cited by 15
Subclinical Cushing’s Syndrome
Beuschlein, F., & Reincke, M. (2005) · Springer eBooks · doi:10.1007/3-540-26861-8_7 · Cited by 15
Adrenocortical Tumorigenesis
Beuschlein, F., & Reincke, M. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1366.001 · Cited by 15
Role of adrenal gland scintigraphy in patients with subclinical hypercortisolism and incidentally discovered adrenal mass
Donadio, F., Morelli, V., Salcuni, A. S., Eller-Vainicher, C., Carletto, M., Castellani, M., Dellavedova, L., Scillitani, A., Beck-Peccoz, P., & Chiodini, I. (2009) · Journal of Endocrinological Investigation · doi:10.1007/bf03346511 · Cited by 13
First in human randomised trial of J2H ‐1702: A novel 11β‐hydroxysteroid dehydrogenase type 1 inhibitor for non‐alcoholic steatohepatitis treatment
Kim, Y., Lee, S. W., & Lee, S. W. (2023) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.17726 · Cited by 13
Prevalence of adrenal masses in Japanese patients with type 2 diabetes mellitus
Hiroi, N., Sue, M., Yoshihara, A., Ichijo, T., Yoshida-Hiroi, M., Higa, M., & Yoshino, G. (2010) · Diabetology & Metabolic Syndrome · doi:10.1186/1758-5996-2-71 · Cited by 12
Cyclic Subclinical Hypercortisolism: A Previously Unidentified Hypersecretory Form of Adrenal Incidentalomas
Giorgi, R. B., Correa, M. V., Costa‐Barbosa, F. A., & Kater, C. E. (2019) · Journal of the Endocrine Society · doi:10.1210/js.2018-00385 · Cited by 12
Adrenal mass in patients who underwent abdominal computed tomography examination
El-Menyar, A. A., Al-Sulaiti, M., Elgohary, H., Almalki, A., Asim, M., Tabeb, A., & Al-Thani, H. A. S. (2015) · North American Journal of Medical Sciences · doi:10.4103/1947-2714.157482 · Cited by 12
Accuracy of new recommendations for adrenal incidentalomas in the evaluation of excessive cortisol secretion and follow‐up
Ruiz, A., Michalopoulou, T., Megía, A., Näf, S., Simón‐Muela, I., Solano, E., Martínez, L., & Vendrell, J. J. (2018) · European Journal of Clinical Investigation · doi:10.1111/eci.13048 · Cited by 12

Authors: Barzon, L., Fallo, F., Sonino, N., & Boscaro, M.
Affiliations: University of Padua (IT)
Corresponding author: Boscaro, M
ORCID: Barzon, L
Fallo, F
Boscaro, M
Venue: European Journal of Endocrinology
Publisher: Oxford University Press (OUP)
Published: 2002-01-01
Volume: 146
Issue: 1
Pages: 61-66
ISSN: 0804-4643 (ISSN-L)
1479-683X
DOI: 10.1530/eje.0.1460061
OpenAlex: W2140530355
Cited by: 162
References: 16
Citations by year: 2026: 1 · 2025: 1 · 2024: 1 · 2023: 4 · 2021: 1 · 2020: 7 · 2019: 5 · 2018: 4 · 2017: 8 · 2016: 5 · 2015: 10 · 2014: 16 · 2013: 8 · 2012: 13
FWCI: 6.05
Type: journal article
Language: en
Open access: green
hdl.handle.net
Licence: other-oa
Locations: European Journal of Endocrinology (publishedVersion)
PubMed (publishedVersion)
Università Politecnica delle Marche (Università Politecnica delle Marche) (submittedVersion)
Padua Research Archive (University of Padova) (submittedVersion, other-oa)
Topics: Health Sciences › Medicine › Surgery › Adrenal and Paraganglionic Tumors
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
Keywords: adrenal incidentaloma, subclinical Cushing's syndrome, subclinical hypercortisolism, progression risk, cumulative risk, follow-up
MeSH terms: Adolescent, Adrenal Gland Neoplasms, Adult, Aged, Cushing Syndrome, Female, Follow-Up Studies, Hormones, Humans, Male, Middle Aged, Disease Progression

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Development of overt Cushing’s syndrome in patients with adrenal incidentaloma

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks